» Authors » Sebastian Pintea

Sebastian Pintea

Explore the profile of Sebastian Pintea including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 17
Citations 298
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Puia A, Pop S, Manzat B, Pintea S, Puia I, Fadgyas-Stanculete M
Medicina (Kaunas) . 2025 Feb; 61(2). PMID: 40005428
: The COVID-19 pandemic has posed unprecedented challenges to healthcare workers, leading to significant psychological distress, altered health-related behaviors, and reliance on various coping mechanisms. Understanding these impacts is critical...
2.
Pintea S, Maier P
J Psychosom Res . 2024 Jul; 184:111837. PMID: 38954864
Objective: This meta-analysis synthesizes research on the impact of cognitive restructuring on chronic pain intensity, aiming to integrate diverse methodologies and findings while evaluating potential moderators. Methods: Following PRISMA guidelines,...
3.
Tohanean N, Tucan P, Vanta O, Abrudan C, Pintea S, Gherman B, et al.
J Clin Med . 2023 Jan; 12(2). PMID: 36675354
The research aimed to evaluate the efficacy of the NeuroAssist, a parallel robotic system comprised of three robotic modules equipped with human-robot interaction capabilities, an internal sensor system for torque...
4.
Radu M, Ciuca A, Crisan C, Pintea S, Predescu E, Sipos R, et al.
Perspect Psychiatr Care . 2022 Mar; 58(4):2372-2382. PMID: 35347717
Purpose: The study investigates the predictors of caregivers' experienced burden, stigma, and well-being, when looking after family members diagnosed with a psychiatric disorder. Design And Methods: This cross-sectional study included...
5.
Vidra R, Nemes A, Vidrean A, Pintea S, Tintari S, Deac A, et al.
Exp Ther Med . 2021 Dec; 23(1):91. PMID: 34934456
The addition of platinum compounds to standard neoadjuvant chemotherapy (NACT) for triple-negative breast cancer (TNBC) is highly controversial. Platinum agents, such as cisplatin and carboplatin, are DNA-damaging agents which exhibit...
6.
Pop-Bica C, Pintea S, Magdo L, Cojocneanu R, Gulei D, Ferracin M, et al.
Front Oncol . 2020 Nov; 10:516850. PMID: 33194579
Non-small cell lung cancer (NSCLC) remains a problem worldwide due to its rapid progression and low rate of response to treatment. The heterogeneity of these tumors observed in histopathology exam...
7.
Ciuca A, Moldovan R, Pintea S, Dumitrascu D, Baban A
J Gastrointestin Liver Dis . 2020 Oct; 29(4):529-537. PMID: 33118538
Background And Aims: Colorectal cancer (CRC) is the third most frequent form of cancer worldwide, and approximately one third of cases have a positive family history of CRC or associated...
8.
Irimie-Aghiorghiesei A, Pop-Bica C, Pintea S, Braicu C, Cojocneanu R, Zimta A, et al.
J Clin Med . 2019 Nov; 8(12). PMID: 31766478
Head and neck squamous cell carcinoma (HNSCC) is a group of malignancies with serious impact on patient quality of life due to a reduced rate of response to chemotherapy or...
9.
Vanta O, Tohanean N, Pintea S, Perju-Dumbrava L
J Clin Med . 2019 Sep; 8(10). PMID: 31554346
(1) Background: Increased attention has lately been given to polyneuropathy in Parkinson's Disease (PD). Several papers postulated that large-fiber neuropathy (PNP) in PD is related to vitamin B12 deficiency and...
10.
Radu M, Moldovan R, Pintea S, Baban A, Dumitrascu D
J Gastrointestin Liver Dis . 2018 Sep; 27(3):257-263. PMID: 30240469
Background And Aims: Cognitive behavioural therapy (CBT) has small to medium effects in alleviating emotional distress and psychosomatic symptoms in irritable bowel syndrome (IBS). However, the mechanism through which CBT...